Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (EU) č. 618/2012

xx xxx 10. čxxxxxxx 2012,

kterým xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; vědecko-technickému pokroku xěx&xxxxxx; nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x Xxxx (XX) č. 1272/2008 x xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x balení látek x xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx xxx XXX)

XXXXXXX&Xxxxxx; XXXXXX,

x&xxxx;xxxxxxx na Xxxxxxx x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; unie,

s ohledem xx nařízení Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) č.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx 2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, o změně x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/EHS x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx xx čx.&xxxx;37 xxxx. 5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

vzhledem x&xxxx;xěxxx xůxxxůx:

(1)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 obsahuje xxx xxxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek. X&xxxx;xxxxxxx 3.1 xx xxxxxx xxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx na x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx v částech 2 xž 5 xř&xxxxxx;xxxx I nařízení (ES) č.&xxxx;1272/2008. V tabulce 3.2 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx klasifikací x xxxxčxx&xxxxxx; nebezpečných látek xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx v příloze XX xxěxxxxx Xxxx 67/548/EHS xx xxx 27.&xxxx;čxxxxx 1967 x xxxxžxx&xxxxxx;x&xxxxxx; xx&xxxxxx;xx&xxxxxx;xx x xxx&xxxxxx;xx&xxxxxx;xx xřxxxxxů x&xxxxxx;xxx&xxxxxx;x&xxxxxx;xx xx xxxxxxxxxxx, xxxxx&xxxxxx; a xxxxčxx&xxxxxx;x&xxxxxx; nebezpečných látek (2). Xxxx xxx xxxxxxx xx xxxx&xxxxxx; xxěxxx, xxx do nich xxxx xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxxxx;xxx, xx xxxx&xxxxxx; xx xxž xxxxxxxx xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx, x xxx xxxxxxxxxx x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx.

(2)

X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; xxxxx Xxxxxxx&xxxxxx; xxxxxxxx xxx xxxxxxx&xxxxxx; látky (XXXX) vydal stanoviska x x&xxxxxx;xxxůx harmonizované xxxxxxxxxxx a xxxxčxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxx, které byly xřxxxxžxxx xxxxxxřx x xxxxxxx x čx&xxxxxx;xxxx 37 xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008. Xx x&xxxxxx;xxxxě xěxxxx stanovisek x xx x&xxxxxx;xxxxě xřxxxx&xxxxxx;xxx xxxxžxx&xxxxxx;xx xx xxxčxx&xxxxxx;xx xxxxx je xřxxx xxěxxx přílohu XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, aby xxxx xxxxžxxx harmonizace xxxxxxxxxxx x xxxxčxx&xxxxxx;x&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(3)

Harmonizované xxxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx VI xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xx xxěx&xxxxxx; xxxxxx nařízení, xx xx neměly xxxž&xxxxxx;x bezprostředně, neboť xxxxxx&xxxxxx;řxx&xxxxxx; subjekty budou xxxřxxxxxx xxčxx&xxxxxx; období xx xx, xxx xxxxx novým klasifikacím xřxxxůxxxxx označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx; a xxxxxx xxxxxxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxxxx&xxxxxx;řxx&xxxxxx; xxxxxxxx xxxxx xxxxě xxxx potřebovat xxčxx&xxxxxx; časové xxxxx&xxxxxx; xx xx, xxx xxxxx xxxxxx xxxxxxxxxx xxx registraci, které xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx xxxxxxxxxxxx&xxxxxx;xx xxxx xxxxxxxxxxx&xxxxxx;, xxxxxxxx&xxxxxx; xxxx toxické xxx xxxxxxxxxx, xxxxxxxx&xxxxxx; 1X x&xxxx;1X (xxxxxxx 3.1) x&xxxx;xxxxxxxx&xxxxxx; 1 x&xxxx;2 (xxxxxxx 3.2) nebo xxxx xxxxxx xxxxxx&xxxxxx; xxx vodní xxxxxxxxx x&xxxx;xxžxxxx&xxxxxx; xxxxxxx xxxxxxxxx&xxxxxx; xxxř&xxxxxx;xxxx&xxxxxx; účinky xx xxxx&xxxxxx;x xxxxxřxx&xxxxxx;, xxxx&xxxxxx;xx xxx xxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;čx&xxxxxx;xxx&xxxx;23 nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx 2006 x&xxxx;xxxxxxxxxx, xxxxxxxx&xxxxxx;, xxxxxxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; xxxxxxx&xxxxxx;xx x&xxxxxx;xxx, x&xxxx;xř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx; agentury pro xxxxxxx&xxxxxx; x&xxxxxx;xxx, o změně xxěxxxxx 1999/45/XX x&xxxx;x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Rady (XXX) č.&xxxx;793/93, nařízení Xxxxxx (XX) č. 1488/94, xxěxxxxx Xxxx 76/769/XXX a směrnic Xxxxxx 91/155/EHS, 93/67/EHS, 93/105/XX x&xxxx;2000/21/XX (3).

(4)

X&xxxx;xxxxxxx s přechodným xxxxxxxxx&xxxxxx;x nařízení (XX) č. 1272/2008, které xxxžňxxx xžxx&xxxxxx; xxx&xxxxxx;xx xxxxxxxxx&xxxxxx; x&xxxx;xřxxxxxxxx xx x&xxxxxx;xx xxxxxxxxxxxxx, xx xěxx mít dodavatelé xxžxxxx xxxž&xxxxxx;xxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xx xxěx&xxxxxx; xxxxxx nařízení, x xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x xxxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x způsobem xx xxxxxxxxx&xxxxxx; bázi xřxx 1. xxxxxxxxx 2013.

(5)

Xxxxřxx&xxxxxx; stanovená x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x&xxxx;xxxxxxx xx stanoviskem výboru xř&xxxxxx;xxx&xxxxxx;xx podle čx&xxxxxx;xxx 133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX XXXX XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx&xxxx;1

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX nařízení (XX) č.&xxxx;1272/2008 se mění xxxxx:

1)

Xxxxxxx 3.1 se xěx&xxxxxx; xxxxx:

a)

záznamy, které xxxxx&xxxxxx;xxx&xxxxxx; záznamům uvedeným x příloze I, xx nahrazují x&xxxxxx;xxxxx xxxxxxxx&xxxxxx;xx x&xxxx;xxxxxx&xxxxxx; xř&xxxxxx;xxxx;

b)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; x příloze XX xx xxx&xxxxxx;xxx&xxxxxx; x souladu x xxxxxxxxxxx&xxxxxx; x&xxxxxx;xxxxů stanovených x&xxxx;xxxxxxx 3.1

2)

Xxxxxxx 3.2 xx xěx&xxxxxx; takto:

x)

záznamy, xxxx&xxxxxx; xxxxx&xxxxxx;xxx&xxxxxx; x&xxxxxx;xxxxůx xxxxxx&xxxxxx;x x xř&xxxxxx;xxxx XXX, xx xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx xxxxxxxx&xxxxxx;xx v uvedené xř&xxxxxx;xxxx;

x)

x&xxxxxx;xxxxx xxxxxx&xxxxxx; v xř&xxxxxx;xxxx XX se xxx&xxxxxx;xxx&xxxxxx; x xxxxxxx x xxxxxxxxxxx&xxxxxx; záznamů xxxxxxxx&xxxxxx;xx v tabulce 3.2

Čx&xxxxxx;xxx&xxxx;2

Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x dnem xx vyhlášení x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; xxxx.

Článek 1 xx použije xxx dne 1. xxxxxxxx 2013.

Harmonizované xxxxxxxxxxx xxxxxxxx&xxxxxx; x&xxxx;č&xxxxxx;xxx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;, xxx použít před 1.&xxxx;xxxxxxxxx 2013.

Xxxx xxř&xxxxxx;xxx&xxxxxx; xx x&xxxxxx;xxxx&xxxxxx; x&xxxx;xxx&xxxxxx;x xxxxxxx x&xxxx;xř&xxxxxx;xx xxxžxxxxx&xxxxxx; ve x&xxxxxx;xxx čxxxxx&xxxxxx;xx státech.

X Xxxxxxx xxx 10. čxxxxxxx 2012.

Xx Xxxxxx

Xxx&xxxxxx; Xxxxxx XXXXXXX

xřxxxxxx

(1)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;&Xxxxxx;ř. věst. 196, 16.8.1967, x. 1.

(3)&xxxx;&xxxx;&Xxxxxx;ř.&xxxx;xěxx.&xxxx;X&xxxx;136, 29.5.2007, x.&xxxx;3.

XŘ&Xxxxxx;XXXX&xxxx;X

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Mezinárodní xxxxxxxxxxxx xxxxxxx&xxxxxx;xx látek

Č&xxxxxx;xxx XX

Č&xxxxxx;xxx XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx, xxxxxxxxxxčx&xxxxxx; xxxxxxx

Xxxx.

X&xxxxxx;xx xř&xxxxxx;x x xxxxxxxx&xxxxxx; nebezpečnosti

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx xxxxxxů x xxxx&xxxxxx;xx&xxxxxx;xx slov

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx doplň. standardních xěx x xxxxxxxčxxxxx

&xxxxx;009-016-00-2

trisodium xxxxxxxxxxxxxxxxxxx [1]

237-410-6 [1]

13775-53-6 [1]

XXXX RE 1

Acute Xxx. 4

Aquatic Xxxxxxx 2

X372

X332

X411

XXX07

XXX08

XXX09

Xxx

X372

X332

X411

&xxxx;

&xxxx;

&xxxx;

xxxxxxxxx hexafluoroaluminate (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-xxxxxxxxxxxxx;

ethylene xxxxxx monoethyl ether

203-804-1

110-80-5

Xxxx. Xxx. 3

Xxxx. 1B

Acute Xxx. 3

Acute Xxx. 4

X226

X360XX

X331

X302

XXX02

XXX08

XXX06

Xxx

X226

X360XX

X331

X302

&xxxx;

&xxxx;

&xxxx;

603-025-00-0

xxxxxxxxxxxxxxx

203-726-8

109-99-9

Xxxx. Xxx. 2

Xxxx. 2

Xxx Xxxxx. 2

XXXX XX 3

X225

X351

X319

X335

XXX02

XXX07

XXX08

Xxx

X225

X351

X319

H335

XXX019

STOT XX 3;

X335: X &xx; 25&xxxx;%

Xxx Irrit.2;

X319: X &xx; 25&xxxx;%

&xxxx;

613-016-00-3

fuberidazole (ISO);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. 2

Xxxxx Xxx. 4

XXXX XX 2

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

X302

H373 (srdce)

X317

X400

H410

GHS07

GHS08

XXX09

Xxx

X351

H302

X373 (xxxxx)

X317

X410

&xxxx;

X = 1

&xxxx;

617-001-00-2

di-tert-butyl xxxxxxxx

203-733-6

110-05-4

Xxx. Perox. X

Xxxx. Xxx. 2

Xxxx. 2

H242

X225

X341

XXX02

GHS08

Xxx

H242

X225

H341“

 

 

 

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Xxxxx&xxxxxx;xxxx&xxxxxx; identifikace xxxxxxx&xxxxxx;xx látek

Číslo XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxx&xxxxxx; xxxxxxx. xxxxxx, xxxxxxxxxxčx&xxxxxx; xxxxxxx

Pozn.

X&xxxxxx;xx tříd x kategorií xxxxxxxčxxxxx

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx x xxxxxxxčxxxxx

X&xxxxxx;xx x&xxxxxx;xxxxžx&xxxxxx;xx symbolů x xxxx&xxxxxx;xx&xxxxxx;xx slov

X&xxxxxx;xx xxxxxxxxx&xxxxxx;xx xěx o xxxxxxxčxxxxx

X&xxxxxx;xx xxxxň. xxxxxxxxx&xxxxxx;xx xěx x nebezpečnosti

&xxxxx;015-199-00-X

xxxx[2-xxxxxx-1-xxxxxxxxxxxx)xxxxx] xxxxxxxxx

237-159-2

13674-87-8

Xxxx. 2

X351

XXX08

Wng

X351

&xxxx;

 

&xxxx;

015-200-00-3

xxxxxx phosphide

244-959-5

22398-80-7

Xxxx. 1X

Xxxx. 2

STOT XX 1

X350

X361x

X372 (plíce)

GHS08

Xxx

X350

X361x

X372 (plíce)

 

STOT XX 1;

X372: C ≥ 0,1 %

Carc 1X;

X350: X&xxxx;&xx;&xxxx;0,01&xxxx;%

XXXX XX 2;

X373: 0,01&xxxx;%&xxxx;&xx; C < 0,1 %

&xxxx;

015-201-00-9

xxxxxxxx xxxxxxxxx

246-677-8

25155-23-1

Xxxx. 1B

H360F

XXX08

Xxx

X360X

&xxxx;

 

 

015-202-00-4

xxxx(xxxxxxxxxxx) phosphite

247-759-6

26523-78-4

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

X400

H410

XXX07

XXX09

Xxx

X317

H410

&xxxx;

 

&xxxx;

015-203-00-X

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxx xxxxx

278-355-8

75980-60-8

Xxxx. 2

X361x (xxůxxxxxx xxxxxxx xxxxxx)

XXX08

Xxx

X361x (xxůxxxxxx xxxxxxx varlat)

&xxxx;

 

&xxxx;

602-109-00-4

Xxxxxxxxxxxxxxxxxxxxxx [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. 2

Xxxx.

X361

X362

XXX08

Xxx

H361

X362

&xxxx;

&xxxx;

&xxxx;

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

abamectin (xxxxxxxxxxx of xxxxxxxxxx X1x and xxxxxxxxxx X1x) (XXX) [1]

_ [1]

71751-41-2 [1]

Repr. 2

Acute Xxx. 2

Acute Xxx. 1

XXXX XX 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X300

X330

X372 (xxxxxx&xxxxxx; xxxx&xxxxxx;x)

H400

H410

GHS06

GHS08

XXX09

Dgr

X361x

H300

X330

X372 (xxxxxx&xxxxxx; xxxx&xxxxxx;x)

H410

&xxxx;

XXXX RE 1;

X372: X&xxxx;&xx;&xxxx;5&xxxx;%

XXXX XX 2;

X373: 0,5 % ≤ X&xxxx;&xx;&xxxx;5&xxxx;%

X&xxxx;=&xxxx;10&xxxx;000

 

xxxxxxxxxx X1x (xxxxxx ≥ 80 %); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx xxxxxxx

&xxxxx;

57960-19-7

Xxxx Sens. 1

XXXX XX 1

XXXX XX 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

H370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (xxxxx&xxxxxx; oběh)

X400

X410

XXX07

XXX08

GHS09

Xxx

X317

X370 (xx&xxxxxx;xx)

(xxxxxxx&xxxxxx;x&xxxxxx;)

X373 (xxxxx&xxxxxx; oběh)

X410

&xxxx;

M = 1 000

 

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. 1X

XXXX RE 1

Xxxxx Xxx. 4

X360X

X372

X302

XXX07

XXX08

Xxx

X360X

X372

X302

 

&xxxx;

&xxxx;

612-281-00-2

leucomalachite xxxxx;

X,X,X',X'-xxxxxxxxxxx-4,4'-xxxxxxxxxxxxxxxxxxxx

204-961-9

129-73-7

Xxxx. 2

Xxxx. 2

X351

X341

XXX08

Xxx

H351

X341

&xxxx;

 

 

616-205-00-9

Xxxxxxxxxxx (XXX);

2-xxxxxx-X-(2,6-xxxxxxxxxxxxxx)-X-(1X-xxxxxxx-1-xxxxxxxx)xxxxxxxxx

266-583-0

67129-08-2

Xxxx Sens. 1X

Xxxx. 2

Xxxxxxx Acute 1

Aquatic Xxxxxxx 1

X317

X351

X400

X410

GHS07

XXX08

GHS09

Wng

X317

X351

X410

&xxxx;

X&xxxx;=&xxxx;100

M = 100“

&xxxx;

XŘ&Xxxxxx;XXXX&xxxx;XXX

Xxxxxxx&xxxxxx; číslo

Xxxxx&xxxxxx;xxxx&xxxxxx; xxxxxxxxxxxx xxxxxxx&xxxxxx;xx látek

Č&xxxxxx;xxx XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; limity

Xxxx.

&xxxxx;009-016-00-2

trisodium xxxxxxxxxxxxxxxxxxx [1]

237-410-6 [1]

13775-53-6 [1]

Xn; X20

X; R48/23/25

X; R51-53

X; X

X: 20-48/23/25-51/53

S: (1/2-)22-37-45-61

&xxxx;

&xxxx;

xxxxxxxxx xxxxxxxxxxxxxxxxxxx (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

603-012-00-X

2-ethoxyethanol;

ethylene xxxxxx xxxxxxxxx xxxxx

203-804-1

110-80-5

X10

Repr. Cat. 2; X60-61

Xx; X20/22

X

R: 60-61-10-20/22

X: 53-45

 

X

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

X; X11-19

Xxxx. Xxx. 3; X40

Xx; X36/37

X; Xx

R: 11-19-40-36/37

X: (2-)(13-)16-29-33-36-37(-46)

Xx; X36/37: C ≥ 25 %

 

613-016-00-3

fuberidazole (XXX);

2-(2-xxxxx)-1X-xxxxxxxxxxxxx

223-404-0

3878-19-1

Xxxx. Cat. 3; X40

Xx; X48/22

Xn; X22

Xx; X43

X; X50-53

Xn; N

R: 40-48/22-22-43-50/53

X: (2)-22-36/37-60-61

N; X50-53: X&xxxx;&xx;&xxxx;25&xxxx;%

X; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25&xxxx;%&xxxx;&xx;&xxxx;X&xxxx;&xx;&xxxx;2,5&xxxx;%

&xxxx;

617-001-00-2

xx-xxxx-xxxxx xxxxxxxx

203-733-6

110-05-4

X; X7

X; X11

Xxxx. Cat. 3, X68

X; X; Xx

X: 7-11-68

X: (2-)3/7-14-16-23-36/37/39“

&xxxx;

 

XŘ&Xxxxxx;XXXX&xxxx;XX

Xxxxxxx&xxxxxx; č&xxxxxx;xxx

Mezinárodní xxxxxxxxxxxx xxxxxxx&xxxxxx;xx látek

Číslo XX

Číslo XXX

Xxxxxxxxxxx

Xxxxčxx&xxxxxx;

Xxxxxxxxxčx&xxxxxx; xxxxxx

Xxxx.

&xxxxx;015-199-00-X

tris[2-chloro-1-chloromethyl)ethyl] xxxxxxxxx

237-159-2

13674-87-8

Xxxx. Xxx. 3; X40

Xx

X: 40

X: (2-)36/37

 

&xxxx;

015-200-00-3

xxxxxx xxxxxxxxx

244-959-5

22398-80-7

Carc. Xxx. 2; R45

Repr. Xxx. 3; X62

X; X48/23

X

X: 45&xxxxx;48/23&xxxxx;62

S: 45- 53

X; X48/23: X &xx;0,1%

Xxxx Xxx 2; X45: X &xx; 0,01%

Xx; R48/20: 0,01%≤ X &xx; 0,1%

E

015-201-00-9

trixylyl xxxxxxxxx

246-677-8

25155-23-1

Xxxx. Cat. 2; X60

X

X: 60

X: 53-45

&xxxx;

&xxxx;

015-202-00-4

tris(nonylphenyl) xxxxxxxxx

247-759-6

26523-78-4

Xx; X43

N; R50-53

Xx; X

X: 43-50/53

X: 24-37-60-61

 

 

015-203-00-X

xxxxxxxx(2,4,6-xxxxxxxxxxxxxxxx)xxxxxxxxx xxxxx

278-355-8

75980-60-8

Xxxx. Xxx. 3; X62

Xx

X: 62

S: (2)-22-36/37.

 

 

602-109-00-4

Hexabromocyclododecane [1]

247-148-4 [1]

25637-99-4[1]

Xxxx. Xxx.&xxxx;3; X63 R64

Xn

R: 63-64

X: 36/37-53

&xxxx;

&xxxx;

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxxxx [2]

221-695-9[2]

3194-55-6[2]

606-143-00-0

xxxxxxxxx (xxxxxxxxxxx xx avermectin X1x xxx xxxxxxxxxx X1x) (XXX) [1]

_ [1]

71751-41-2 [1]

Xxxx. Cat. 3; R63

X+; X26/28

X; X48/23/25

N; R50-53

X+; X

X: 63-26/28-48/23/25-50/53

X: 28-36/37-45-60-61

T; X48/23: X &xx; 5%

Xx; X48/20: 0,5% &xx; C &xx;5%

X; X50-53: C &xx; 0,0025%

X; X51-53: 0,00025% &xx; C <0,0025%

R52-53: 0,000025% &xx; X&xx;0,00025%

 

xxxxxxxxxx X1x (xxxxxx &xx;80%); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

xxxxxxxxxxx (XXX);

3-xxxxxxx-1,4-xxxxx-1,4-xxxxxxxxxxxxxxxxx-2-xx acetate

&xxxxx;

57960-19-7

X; X39/23

Xx; X43

X; X50-53

X; X

X: 39/23-43-50/53,

X: (2-)24-37-38-60-61

X; X50-53: X ≥ 0,025%

X; X51-53: 0,0025% ≤ X &xx; 0,025%

R52-53: 0,00025% ≤ X &xx; 0,0025%

 

607-698-00-1

4-xxxx-xxxxxxxxxxxx xxxx

202-696-3

98-73-7

Xxxx. Xxx. 2; R60

X; X48/23/24/25

Xx; X22

X

R: 60-22-48/23/24/25

X: 53-45

&xxxx;

X

612-281-00-2

xxxxxxxxxxxxxx xxxxx

X,X,X',X'-xxxxxxxxxxx-4,4'-xxxxxxxxxxxxxxxxxxxx

204-961-9

129-73-7

Xxxx. Xxx.&xxxx;3;X40

Xxxx. Xxx. 3; X68

Xn

X: 40-68

X: (2-)36/37

 

&xxxx;

616-205-00-9

Xxxxxxxxxxx (XXX);

2-xxxxxx-X-(2,6-xxxxxxxxxxxxxx)-X-(1X-xxxxxxx-1-xxxxxxxx)xxxxxxxxx

266-583-0

67129-08-2

R43

Carc. Xxx. 3; R40

N; X50-53

Xx; N

X: 40-43-50/53

X: (2-)36-37-60-61

X; X50-53: X &xx; 0,25%

X; X51-53: 0,025% &xx; X &xx; 0,25%

X52-53: 0,0025% &xx; X &xx; 0,025%&xxxxx;

&xxxx;